The ten–eleven translocation (TET) family of methylcytosine dioxygenases initiates
demethylation of DNA and is associated with tumorigenesis in many cancers; however, the …

BN ip3 is a hypoxia‐inducible protein that targets mitochondria for autophagosomal
degradation. We report a novel tumor suppressor role for BN ip3 in a clinically relevant mouse …

Mitochondrial metabolism is an attractive target for cancer therapy 1 , 2 . Reprogramming
metabolic pathways could improve the ability of metabolic inhibitors to suppress cancers with …

Tumour metastasis suppressors are inhibitors of metastasis but their mechanisms of action
are generally not understood. We previously showed that the suppressor Raf kinase …

The sources and consequences of nongenetic variability in metastatic progression are
largely unknown. To address these questions, we characterized a transcriptional regulatory …

Background SARS‐CoV‐2 is a global pandemic associated with significant morbidity and
mortality. However, information from United States cohorts is limited. Understanding predictors …

Triple-negative breast cancer (TNBC) patients have the highest risk of recurrence and
metastasis. Because they cannot be treated with targeted therapies, and many do not respond to …

Elucidating targets of physiological tumor metastasis suppressors can highlight key
signaling pathways leading to invasion and metastasis. To identify downstream targets of the …

Although triple negative breast cancers (TNBC) are the most aggressive subtype of breast
cancer, they currently lack targeted therapies. Because this classification still includes a …

We have developed a clinically validated NGS assay that includes tumor, germline and RNA
sequencing. We apply this assay to clinical specimens and cell lines, and we demonstrate …